Loading…
Reduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar Consumption
The subthalamic nucleus (STN) plays a central role in motor, cognitive, and affective behavior. Deep brain stimulation (DBS) of the STN is the most common surgical intervention for advanced Parkinson's disease (PD), and STN has lately gained attention as target for DBS in neuropsychiatric disor...
Saved in:
Published in: | eNeuro 2016-09, Vol.3 (5), p.ENEURO.0264-16.2016 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c447t-7f1e9bcc8dfba581bb7aa72ae1d07c0d735bfd0db9e6b3ee9bc1f4b3a9b94e873 |
---|---|
cites | cdi_FETCH-LOGICAL-c447t-7f1e9bcc8dfba581bb7aa72ae1d07c0d735bfd0db9e6b3ee9bc1f4b3a9b94e873 |
container_end_page | |
container_issue | 5 |
container_start_page | ENEURO.0264-16.2016 |
container_title | eNeuro |
container_volume | 3 |
creator | Schweizer, Nadine Viereckel, Thomas Smith-Anttila, Casey J A Nordenankar, Karin Arvidsson, Emma Mahmoudi, Souha Zampera, André Wärner Jonsson, Hanna Bergquist, Jonas Lévesque, Daniel Konradsson-Geuken, Åsa Andersson, Malin Dumas, Sylvie Wallén-Mackenzie, Åsa |
description | The subthalamic nucleus (STN) plays a central role in motor, cognitive, and affective behavior. Deep brain stimulation (DBS) of the STN is the most common surgical intervention for advanced Parkinson's disease (PD), and STN has lately gained attention as target for DBS in neuropsychiatric disorders, including obsessive compulsive disorder, eating disorders, and addiction. Animal studies using STN-DBS, lesioning, or inactivation of STN neurons have been used extensively alongside clinical studies to unravel the structural organization, circuitry, and function of the STN. Recent studies in rodent STN models have exposed different roles for STN neurons in reward-related functions. We have previously shown that the majority of STN neurons express the vesicular glutamate transporter 2 gene (
) and that reduction of Vglut2 mRNA levels within the STN of mice [conditional knockout (cKO)] causes reduced postsynaptic activity and behavioral hyperlocomotion. The cKO mice showed less interest in fatty rewards, which motivated analysis of reward-response. The current results demonstrate decreased sugar consumption and strong rearing behavior, whereas biochemical analyses show altered dopaminergic and peptidergic activity in the striatum. The behavioral alterations were in fact correlated with opposite effects in the dorsal versus the ventral striatum. Significant cell loss and disorganization of the STN structure was identified, which likely accounts for the observed alterations. Rare genetic variants of the human
gene exist, and this study shows that reduced
gene expression levels exclusively within the STN of mice is sufficient to cause strong modifications in both the STN and the mesostriatal dopamine system. |
doi_str_mv | 10.1523/ENEURO.0264-16.2016 |
format | article |
fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_DiVA_org_uu_315932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1835367439</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-7f1e9bcc8dfba581bb7aa72ae1d07c0d735bfd0db9e6b3ee9bc1f4b3a9b94e873</originalsourceid><addsrcrecordid>eNpVkt9O2zAUxqNp00CMJ5g0-XIXa4ntJE5uJlVtYUgFJDq4tWznpPXkxp3_FLpH3FPNWQHBlY91fufz8acvyz7jfIxLQs_m1_O725txTqpihKsxyXH1LjsmlNERqQl5_6o-yk69_5XnCSEM1_hjdkRY1TQEk-Ps7y20UUGL7lcmBnK2NAozUaEL6AHNH7cOvNe2RwvYgfEorJ2Nq7WNIZWArmz0gJZRhrUwYqMVuo7KQPRoKobOFIxBC-s9En2LlsFFFaITBs20t24lev1HhEH-3BpjH9Iaco8ue-VA-HS5ssE6NFFB73TY_9eYwXNzGVfCoantfdxsB5FP2YdOGA-nT-dJdnc-_zn9MVrcXFxOJ4uRKgoWRqzD0Eil6raToqyxlEwIRgTgNmcqbxktZdfmrWygkhQGFneFpKKRTQE1oyfZt4Ouf4BtlHzr9Ea4PbdC85m-n_D0Mx4jp7hsKEn49wOe2A20CvqQHHgz9bbT6zVf2R0v8wLjqkgCX58EnP0dwQe-0V4lZ0UPyX-Oa1rSihW0SSg9oMol0x10L8_gnA-54Yfc8CE3HFd8yE2a-vJ6w5eZ55TQf_Z4xh8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835367439</pqid></control><display><type>article</type><title>Reduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar Consumption</title><source>PMC (PubMed Central)</source><creator>Schweizer, Nadine ; Viereckel, Thomas ; Smith-Anttila, Casey J A ; Nordenankar, Karin ; Arvidsson, Emma ; Mahmoudi, Souha ; Zampera, André ; Wärner Jonsson, Hanna ; Bergquist, Jonas ; Lévesque, Daniel ; Konradsson-Geuken, Åsa ; Andersson, Malin ; Dumas, Sylvie ; Wallén-Mackenzie, Åsa</creator><creatorcontrib>Schweizer, Nadine ; Viereckel, Thomas ; Smith-Anttila, Casey J A ; Nordenankar, Karin ; Arvidsson, Emma ; Mahmoudi, Souha ; Zampera, André ; Wärner Jonsson, Hanna ; Bergquist, Jonas ; Lévesque, Daniel ; Konradsson-Geuken, Åsa ; Andersson, Malin ; Dumas, Sylvie ; Wallén-Mackenzie, Åsa</creatorcontrib><description>The subthalamic nucleus (STN) plays a central role in motor, cognitive, and affective behavior. Deep brain stimulation (DBS) of the STN is the most common surgical intervention for advanced Parkinson's disease (PD), and STN has lately gained attention as target for DBS in neuropsychiatric disorders, including obsessive compulsive disorder, eating disorders, and addiction. Animal studies using STN-DBS, lesioning, or inactivation of STN neurons have been used extensively alongside clinical studies to unravel the structural organization, circuitry, and function of the STN. Recent studies in rodent STN models have exposed different roles for STN neurons in reward-related functions. We have previously shown that the majority of STN neurons express the vesicular glutamate transporter 2 gene (
) and that reduction of Vglut2 mRNA levels within the STN of mice [conditional knockout (cKO)] causes reduced postsynaptic activity and behavioral hyperlocomotion. The cKO mice showed less interest in fatty rewards, which motivated analysis of reward-response. The current results demonstrate decreased sugar consumption and strong rearing behavior, whereas biochemical analyses show altered dopaminergic and peptidergic activity in the striatum. The behavioral alterations were in fact correlated with opposite effects in the dorsal versus the ventral striatum. Significant cell loss and disorganization of the STN structure was identified, which likely accounts for the observed alterations. Rare genetic variants of the human
gene exist, and this study shows that reduced
gene expression levels exclusively within the STN of mice is sufficient to cause strong modifications in both the STN and the mesostriatal dopamine system.</description><identifier>ISSN: 2373-2822</identifier><identifier>EISSN: 2373-2822</identifier><identifier>DOI: 10.1523/ENEURO.0264-16.2016</identifier><identifier>PMID: 27699212</identifier><language>eng</language><publisher>United States: Society for Neuroscience</publisher><subject>Animals ; Cell Death - physiology ; Conditioning, Operant - physiology ; Corpus Striatum - metabolism ; Corpus Striatum - pathology ; Dietary Sucrose - administration & dosage ; dopamine ; Dopamine Plasma Membrane Transport Proteins - metabolism ; dynorphin ; Feeding Behavior - physiology ; Female ; Gene Expression ; glutamate ; Homeobox Protein PITX2 ; Homeodomain Proteins - metabolism ; Male ; Mice, 129 Strain ; Mice, Inbred C57BL ; Mice, Knockout ; Motivation - physiology ; Motor Activity - physiology ; New Research ; rearing ; Receptors, Dopamine - metabolism ; reward ; RNA, Messenger - metabolism ; Self Administration ; Subthalamic Nucleus - metabolism ; Subthalamic Nucleus - pathology ; Transcription Factors - metabolism ; Vesicular Glutamate Transport Protein 2 - deficiency ; Vesicular Glutamate Transport Protein 2 - genetics</subject><ispartof>eNeuro, 2016-09, Vol.3 (5), p.ENEURO.0264-16.2016</ispartof><rights>Copyright © 2016 Schweizer et al. 2016 Schweizer et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-7f1e9bcc8dfba581bb7aa72ae1d07c0d735bfd0db9e6b3ee9bc1f4b3a9b94e873</citedby><cites>FETCH-LOGICAL-c447t-7f1e9bcc8dfba581bb7aa72ae1d07c0d735bfd0db9e6b3ee9bc1f4b3a9b94e873</cites><orcidid>0000-0002-8701-2690 ; 0000-0001-9039-7707 ; 0000-0002-8713-070X ; 0000-0002-8739-9645</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041164/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041164/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27699212$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-315932$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Schweizer, Nadine</creatorcontrib><creatorcontrib>Viereckel, Thomas</creatorcontrib><creatorcontrib>Smith-Anttila, Casey J A</creatorcontrib><creatorcontrib>Nordenankar, Karin</creatorcontrib><creatorcontrib>Arvidsson, Emma</creatorcontrib><creatorcontrib>Mahmoudi, Souha</creatorcontrib><creatorcontrib>Zampera, André</creatorcontrib><creatorcontrib>Wärner Jonsson, Hanna</creatorcontrib><creatorcontrib>Bergquist, Jonas</creatorcontrib><creatorcontrib>Lévesque, Daniel</creatorcontrib><creatorcontrib>Konradsson-Geuken, Åsa</creatorcontrib><creatorcontrib>Andersson, Malin</creatorcontrib><creatorcontrib>Dumas, Sylvie</creatorcontrib><creatorcontrib>Wallén-Mackenzie, Åsa</creatorcontrib><title>Reduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar Consumption</title><title>eNeuro</title><addtitle>eNeuro</addtitle><description>The subthalamic nucleus (STN) plays a central role in motor, cognitive, and affective behavior. Deep brain stimulation (DBS) of the STN is the most common surgical intervention for advanced Parkinson's disease (PD), and STN has lately gained attention as target for DBS in neuropsychiatric disorders, including obsessive compulsive disorder, eating disorders, and addiction. Animal studies using STN-DBS, lesioning, or inactivation of STN neurons have been used extensively alongside clinical studies to unravel the structural organization, circuitry, and function of the STN. Recent studies in rodent STN models have exposed different roles for STN neurons in reward-related functions. We have previously shown that the majority of STN neurons express the vesicular glutamate transporter 2 gene (
) and that reduction of Vglut2 mRNA levels within the STN of mice [conditional knockout (cKO)] causes reduced postsynaptic activity and behavioral hyperlocomotion. The cKO mice showed less interest in fatty rewards, which motivated analysis of reward-response. The current results demonstrate decreased sugar consumption and strong rearing behavior, whereas biochemical analyses show altered dopaminergic and peptidergic activity in the striatum. The behavioral alterations were in fact correlated with opposite effects in the dorsal versus the ventral striatum. Significant cell loss and disorganization of the STN structure was identified, which likely accounts for the observed alterations. Rare genetic variants of the human
gene exist, and this study shows that reduced
gene expression levels exclusively within the STN of mice is sufficient to cause strong modifications in both the STN and the mesostriatal dopamine system.</description><subject>Animals</subject><subject>Cell Death - physiology</subject><subject>Conditioning, Operant - physiology</subject><subject>Corpus Striatum - metabolism</subject><subject>Corpus Striatum - pathology</subject><subject>Dietary Sucrose - administration & dosage</subject><subject>dopamine</subject><subject>Dopamine Plasma Membrane Transport Proteins - metabolism</subject><subject>dynorphin</subject><subject>Feeding Behavior - physiology</subject><subject>Female</subject><subject>Gene Expression</subject><subject>glutamate</subject><subject>Homeobox Protein PITX2</subject><subject>Homeodomain Proteins - metabolism</subject><subject>Male</subject><subject>Mice, 129 Strain</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Motivation - physiology</subject><subject>Motor Activity - physiology</subject><subject>New Research</subject><subject>rearing</subject><subject>Receptors, Dopamine - metabolism</subject><subject>reward</subject><subject>RNA, Messenger - metabolism</subject><subject>Self Administration</subject><subject>Subthalamic Nucleus - metabolism</subject><subject>Subthalamic Nucleus - pathology</subject><subject>Transcription Factors - metabolism</subject><subject>Vesicular Glutamate Transport Protein 2 - deficiency</subject><subject>Vesicular Glutamate Transport Protein 2 - genetics</subject><issn>2373-2822</issn><issn>2373-2822</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpVkt9O2zAUxqNp00CMJ5g0-XIXa4ntJE5uJlVtYUgFJDq4tWznpPXkxp3_FLpH3FPNWQHBlY91fufz8acvyz7jfIxLQs_m1_O725txTqpihKsxyXH1LjsmlNERqQl5_6o-yk69_5XnCSEM1_hjdkRY1TQEk-Ps7y20UUGL7lcmBnK2NAozUaEL6AHNH7cOvNe2RwvYgfEorJ2Nq7WNIZWArmz0gJZRhrUwYqMVuo7KQPRoKobOFIxBC-s9En2LlsFFFaITBs20t24lev1HhEH-3BpjH9Iaco8ue-VA-HS5ssE6NFFB73TY_9eYwXNzGVfCoantfdxsB5FP2YdOGA-nT-dJdnc-_zn9MVrcXFxOJ4uRKgoWRqzD0Eil6raToqyxlEwIRgTgNmcqbxktZdfmrWygkhQGFneFpKKRTQE1oyfZt4Ouf4BtlHzr9Ea4PbdC85m-n_D0Mx4jp7hsKEn49wOe2A20CvqQHHgz9bbT6zVf2R0v8wLjqkgCX58EnP0dwQe-0V4lZ0UPyX-Oa1rSihW0SSg9oMol0x10L8_gnA-54Yfc8CE3HFd8yE2a-vJ6w5eZ55TQf_Z4xh8</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Schweizer, Nadine</creator><creator>Viereckel, Thomas</creator><creator>Smith-Anttila, Casey J A</creator><creator>Nordenankar, Karin</creator><creator>Arvidsson, Emma</creator><creator>Mahmoudi, Souha</creator><creator>Zampera, André</creator><creator>Wärner Jonsson, Hanna</creator><creator>Bergquist, Jonas</creator><creator>Lévesque, Daniel</creator><creator>Konradsson-Geuken, Åsa</creator><creator>Andersson, Malin</creator><creator>Dumas, Sylvie</creator><creator>Wallén-Mackenzie, Åsa</creator><general>Society for Neuroscience</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>DF2</scope><orcidid>https://orcid.org/0000-0002-8701-2690</orcidid><orcidid>https://orcid.org/0000-0001-9039-7707</orcidid><orcidid>https://orcid.org/0000-0002-8713-070X</orcidid><orcidid>https://orcid.org/0000-0002-8739-9645</orcidid></search><sort><creationdate>20160901</creationdate><title>Reduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar Consumption</title><author>Schweizer, Nadine ; Viereckel, Thomas ; Smith-Anttila, Casey J A ; Nordenankar, Karin ; Arvidsson, Emma ; Mahmoudi, Souha ; Zampera, André ; Wärner Jonsson, Hanna ; Bergquist, Jonas ; Lévesque, Daniel ; Konradsson-Geuken, Åsa ; Andersson, Malin ; Dumas, Sylvie ; Wallén-Mackenzie, Åsa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-7f1e9bcc8dfba581bb7aa72ae1d07c0d735bfd0db9e6b3ee9bc1f4b3a9b94e873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Cell Death - physiology</topic><topic>Conditioning, Operant - physiology</topic><topic>Corpus Striatum - metabolism</topic><topic>Corpus Striatum - pathology</topic><topic>Dietary Sucrose - administration & dosage</topic><topic>dopamine</topic><topic>Dopamine Plasma Membrane Transport Proteins - metabolism</topic><topic>dynorphin</topic><topic>Feeding Behavior - physiology</topic><topic>Female</topic><topic>Gene Expression</topic><topic>glutamate</topic><topic>Homeobox Protein PITX2</topic><topic>Homeodomain Proteins - metabolism</topic><topic>Male</topic><topic>Mice, 129 Strain</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Motivation - physiology</topic><topic>Motor Activity - physiology</topic><topic>New Research</topic><topic>rearing</topic><topic>Receptors, Dopamine - metabolism</topic><topic>reward</topic><topic>RNA, Messenger - metabolism</topic><topic>Self Administration</topic><topic>Subthalamic Nucleus - metabolism</topic><topic>Subthalamic Nucleus - pathology</topic><topic>Transcription Factors - metabolism</topic><topic>Vesicular Glutamate Transport Protein 2 - deficiency</topic><topic>Vesicular Glutamate Transport Protein 2 - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schweizer, Nadine</creatorcontrib><creatorcontrib>Viereckel, Thomas</creatorcontrib><creatorcontrib>Smith-Anttila, Casey J A</creatorcontrib><creatorcontrib>Nordenankar, Karin</creatorcontrib><creatorcontrib>Arvidsson, Emma</creatorcontrib><creatorcontrib>Mahmoudi, Souha</creatorcontrib><creatorcontrib>Zampera, André</creatorcontrib><creatorcontrib>Wärner Jonsson, Hanna</creatorcontrib><creatorcontrib>Bergquist, Jonas</creatorcontrib><creatorcontrib>Lévesque, Daniel</creatorcontrib><creatorcontrib>Konradsson-Geuken, Åsa</creatorcontrib><creatorcontrib>Andersson, Malin</creatorcontrib><creatorcontrib>Dumas, Sylvie</creatorcontrib><creatorcontrib>Wallén-Mackenzie, Åsa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Uppsala universitet</collection><jtitle>eNeuro</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schweizer, Nadine</au><au>Viereckel, Thomas</au><au>Smith-Anttila, Casey J A</au><au>Nordenankar, Karin</au><au>Arvidsson, Emma</au><au>Mahmoudi, Souha</au><au>Zampera, André</au><au>Wärner Jonsson, Hanna</au><au>Bergquist, Jonas</au><au>Lévesque, Daniel</au><au>Konradsson-Geuken, Åsa</au><au>Andersson, Malin</au><au>Dumas, Sylvie</au><au>Wallén-Mackenzie, Åsa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar Consumption</atitle><jtitle>eNeuro</jtitle><addtitle>eNeuro</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>3</volume><issue>5</issue><spage>ENEURO.0264-16.2016</spage><pages>ENEURO.0264-16.2016-</pages><issn>2373-2822</issn><eissn>2373-2822</eissn><abstract>The subthalamic nucleus (STN) plays a central role in motor, cognitive, and affective behavior. Deep brain stimulation (DBS) of the STN is the most common surgical intervention for advanced Parkinson's disease (PD), and STN has lately gained attention as target for DBS in neuropsychiatric disorders, including obsessive compulsive disorder, eating disorders, and addiction. Animal studies using STN-DBS, lesioning, or inactivation of STN neurons have been used extensively alongside clinical studies to unravel the structural organization, circuitry, and function of the STN. Recent studies in rodent STN models have exposed different roles for STN neurons in reward-related functions. We have previously shown that the majority of STN neurons express the vesicular glutamate transporter 2 gene (
) and that reduction of Vglut2 mRNA levels within the STN of mice [conditional knockout (cKO)] causes reduced postsynaptic activity and behavioral hyperlocomotion. The cKO mice showed less interest in fatty rewards, which motivated analysis of reward-response. The current results demonstrate decreased sugar consumption and strong rearing behavior, whereas biochemical analyses show altered dopaminergic and peptidergic activity in the striatum. The behavioral alterations were in fact correlated with opposite effects in the dorsal versus the ventral striatum. Significant cell loss and disorganization of the STN structure was identified, which likely accounts for the observed alterations. Rare genetic variants of the human
gene exist, and this study shows that reduced
gene expression levels exclusively within the STN of mice is sufficient to cause strong modifications in both the STN and the mesostriatal dopamine system.</abstract><cop>United States</cop><pub>Society for Neuroscience</pub><pmid>27699212</pmid><doi>10.1523/ENEURO.0264-16.2016</doi><orcidid>https://orcid.org/0000-0002-8701-2690</orcidid><orcidid>https://orcid.org/0000-0001-9039-7707</orcidid><orcidid>https://orcid.org/0000-0002-8713-070X</orcidid><orcidid>https://orcid.org/0000-0002-8739-9645</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2373-2822 |
ispartof | eNeuro, 2016-09, Vol.3 (5), p.ENEURO.0264-16.2016 |
issn | 2373-2822 2373-2822 |
language | eng |
recordid | cdi_swepub_primary_oai_DiVA_org_uu_315932 |
source | PMC (PubMed Central) |
subjects | Animals Cell Death - physiology Conditioning, Operant - physiology Corpus Striatum - metabolism Corpus Striatum - pathology Dietary Sucrose - administration & dosage dopamine Dopamine Plasma Membrane Transport Proteins - metabolism dynorphin Feeding Behavior - physiology Female Gene Expression glutamate Homeobox Protein PITX2 Homeodomain Proteins - metabolism Male Mice, 129 Strain Mice, Inbred C57BL Mice, Knockout Motivation - physiology Motor Activity - physiology New Research rearing Receptors, Dopamine - metabolism reward RNA, Messenger - metabolism Self Administration Subthalamic Nucleus - metabolism Subthalamic Nucleus - pathology Transcription Factors - metabolism Vesicular Glutamate Transport Protein 2 - deficiency Vesicular Glutamate Transport Protein 2 - genetics |
title | Reduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar Consumption |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T18%3A45%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20Vglut2/Slc17a6%20Gene%20Expression%20Levels%20throughout%20the%20Mouse%20Subthalamic%20Nucleus%20Cause%20Cell%20Loss%20and%20Structural%20Disorganization%20Followed%20by%20Increased%20Motor%20Activity%20and%20Decreased%20Sugar%20Consumption&rft.jtitle=eNeuro&rft.au=Schweizer,%20Nadine&rft.date=2016-09-01&rft.volume=3&rft.issue=5&rft.spage=ENEURO.0264-16.2016&rft.pages=ENEURO.0264-16.2016-&rft.issn=2373-2822&rft.eissn=2373-2822&rft_id=info:doi/10.1523/ENEURO.0264-16.2016&rft_dat=%3Cproquest_swepu%3E1835367439%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c447t-7f1e9bcc8dfba581bb7aa72ae1d07c0d735bfd0db9e6b3ee9bc1f4b3a9b94e873%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1835367439&rft_id=info:pmid/27699212&rfr_iscdi=true |